Exocobio

Developer of exosome-based therapeutics for regenerative medicine

placeSeoul, Seoul, South Korea calendar_todayFounded 2017 groups99 employees language exocobio.com

Innovation

90 patent families (26 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 1,187 times.

YearFilings
20182
201938
202015
202124
202225
202318
202414
20258
20261

Investor mix

17 investors on record; lead investors include ID Ventures, Atinum Investment, SBI Investment Korea, DT&Investment.

Investor typeCountShare
Venture capital847%
Private equity212%
Bank & private debt16%
Other / undisclosed635%
Coming soon